Senvelgo Velagliflozin Oral Solution

164 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

164

Total Reports

Deaths Reported

1460.0%

Death Rate

Active Ingredients

Senvelgo Velagliflozin Oral Solution

Administration Routes

OralUnknownSubcutaneous

Species Affected

Cat 164

Most Affected Breeds

Domestic Shorthair 124

Domestic Longhair 14

Domestic Mediumhair 7

Maine Coon 6

Siamese 5

Crossbred Feline/cat 3

Unknown 1

Russian 1

Burmese 1

American Curl Shorthair 1

Most Reported Reactions

Ketosis 53

Lack of efficacy - NOS 39

Weight loss 38

Vomiting 31

Diarrhoea 28

Lethargy (see also Central nervous system depression in Neurological) 25

Anorexia 22

Death by euthanasia 19

Ketonuria 14

Dehydration 13

Hypokalaemia 12

Diabetic ketoacidosis 11

Outcome Breakdown

Outcome Unknown

100 (61.0%)

Ongoing

26 (15.9%)

Euthanized

20 (12.2%)

Recovered/Normal

12 (7.3%)

Died

4 (2.4%)

Recovered with Sequela

2 (1.2%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.